| Cholangiocarcinoma predicts response to …PREDICTS_RESPONSE_TO27 of 27show fewer |
|---|
| in context · predicts response to | FGFR2 Fusionfusion → predicts response to Infigratinib | sensitivity | A | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | FGFR2 Fusionfusion → predicts response to Infigratinib | sensitivity | A | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | IDH1 R132 → predicts response to Ivosidenib | sensitivity | A | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | IDH1 Mutationother → predicts response to Ivosidenib | sensitivity | B | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | FGFR2 Mutationother → predicts response to Infigratinib | sensitivity | B | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | FGFR2 Fusionfusion → predicts response to Infigratinib | sensitivity | B | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | FGFR2 Fusionfusion → predicts response to Infigratinib | sensitivity | B | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600 → predicts response to Vemurafenib | sensitivity | B | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | FGFR2 Fusionfusion → predicts response to Infigratinib | sensitivity | C | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | FGFR2 Fusionfusion → predicts response to Infigratinib | sensitivity | C | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | FGFR2 Mutationother → predicts response to Infigratinib | sensitivity | C | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | ERRFI1 E384*SNV → predicts response to Erlotinib | sensitivity | C | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | OGA Fusionfusion → predicts response to Ponatinib | sensitivity | C | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Pertuzumab | sensitivity | C | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Trastuzumab | sensitivity | C | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Irinotecan | sensitivity | C | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Panitumumab | sensitivity | C | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Vemurafenib | sensitivity | C | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Dabrafenib | sensitivity | C | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF V600ESNV → predicts response to Trametinib | sensitivity | C | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | NRG1 Fusionfusion → predicts response to Afatinib | sensitivity | C | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | TACC3 Fusionfusion → predicts response to Pazopanib | sensitivity | C | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | TACC3 Fusionfusion → predicts response to Ponatinib | sensitivity | C | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | AHCYL1 Fusionfusion → predicts response to Infigratinib | sensitivity | D | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | AHCYL1 Fusionfusion → predicts response to PD173074 | sensitivity | D | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BICC1 Fusionfusion → predicts response to Infigratinib | sensitivity | D | Cholangiocarcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BICC1 Fusionfusion → predicts response to PD173074 | sensitivity | D | Cholangiocarcinoma | 1 | Curated | civic | graph → |